Ipsalazide

Ipsalazide

SCHEMBL11165440

O=C(O)CNC(=O)c1ccc(N=Nc2ccc(O)c(C(=O)O)c2)cc1

nearest known ligand 0.77

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIRT5 Q9NXA8 4/20 0.77
TDP1 Q9NUW8 3/20 0.77
HRH3 Q9Y5N1 2/20 0.77
NME4 O00746 2/20 0.77
GCDH Q92947 2/20 0.77
ADORA3 P0DMS8 1/20 0.77
CHRM1 P11229 1/20 0.77
ADORA2A P29274 1/20 0.77
AVPR2 P30518 1/20 0.77
AGTR1 P30556 1/20 0.77
SLC6A4 P31645 1/20 0.77
AVPR1A P37288 1/20 0.77
HTR3A P46098 1/20 0.77
SLC29A1 Q99808 1/20 0.77
MEN1 O00255 3/20 0.62
KMT2A Q03164 3/20 0.62
BLVRB P30043 2/20 0.62
PDE4A P27815 1/20 0.62
KDR P35968 1/20 0.62
HTT P42858 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ipsalazide SCHEMBL596652 1.00 SIRT5 (0.77) SIRT5TDP1HRH3NME4GCDH
Balsalazide SCHEMBL3267109 0.87 SIRT5 (1.00) SIRT5TDP1HRH3NME4GCDH
Balsalazide SCHEMBL29377041 0.87 SIRT5 (1.00) SIRT5TDP1HRH3NME4GCDH
Balsalazide SCHEMBL138311 0.87 SIRT5 (1.00) SIRT5TDP1HRH3NME4GCDH
Balsalazide SCHEMBL118300 0.87 SIRT5 (1.00) SIRT5TDP1HRH3NME4GCDH
Balsalazide SCHEMBL134019 0.86 SIRT5 (0.97) SIRT5TDP1HRH3NME4GCDH
Balsalazide SCHEMBL7908058 0.86 SIRT5 (0.97) SIRT5TDP1HRH3NME4GCDH
Balsalazide SCHEMBL28818120 0.86 SIRT5 (0.97) SIRT5TDP1HRH3NME4GCDH
Balsalazide SCHEMBL5598491 0.86 SIRT5 (0.97) SIRT5TDP1HRH3NME4GCDH
SCHEMBL11160268 0.85 SIRT5 (0.79) SIRT5TDP1HRH3NME4GCDH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4412992-A 2-Hydroxy-5-phenylazobenzoic acid derivatives and method of treating ulcerative colitis therewith BIOREX LABORATORIES LIMITED (GB) 1983-11-01 US claimed
CN-111529684-A Use of oral sustained release compositions containing cyclosporin 卓越治疗有限公司 2020-08-14 CN disclosed
US-4412992-A 2-Hydroxy-5-phenylazobenzoic acid derivatives and method of treating ulcerative colitis therewith BIOREX LABORATORIES LIMITED (GB) 1983-11-01 US disclosed